FDA approves new H1N1 vaccine from Novartis

  

WASHINGTON (KGO) -- The Food and Drug Administration has approved a new H1N1 vaccine to help ease the nationwide shortage.

More than seven million doses of swine flu vaccine have been ordered from drug maker Novartis and preliminary test results show a lower dose of the vaccine may be enough to provide immunity from the virus.

The Novartis vaccine should be delivered next month.

Get more Health »

• Comment Now
• Email
• Print
• Report a typo
•